Strategic guidance bridging science, engineering, and commercialization for medical device and diagnostics innovators.
20+ years of R&D leadership • Ivy League postdoctoral training • Commercialization expertise
Execution Focus
Leadership Expertise
Medical innovation is more than good science. It requires clear decisions, experienced leadership, and a practical path forward. We help innovators move confidently from early ideas to real-world medical solutions.
Strategic medical technology leadership built on deep scientific training and real-world commercialization experience.
Fractional CTO | Diagnostics Evangelist | Commercialization Advisor
Michael Harman, PhD brings over 20 years of combined experience across R&D, executive support, and team leadership in the medical technology sector. His career began with an Ivy League clinical postdoctoral fellowship at Brown University and Rhode Island Hospital, where he developed the foundation for translating deep scientific research into practical solutions.
Since then, he has focused on helping innovators bridge the gap between laboratory discoveries and commercial medical products. His expertise spans product strategy, regulatory navigation, and launch execution—with a consistent focus on delivering measurable value to both clients and their investors.
Michael partners with startups, established innovators, and leadership teams to provide the strategic guidance needed to move from concept to market with confidence.
Years of Experience
Postdoctoral Training
We combine deep scientific understanding with practical industry experience, ensuring every decision supports progress, clarity, and real-world impact.
Michael brings deep life sciences expertise and a rare ability to connect technology, engineering, and science. His leadership and insight consistently drive meaningful innovation across the biomedical field.
Mike is one of the most genuine and well-connected people I’ve met in the life sciences industry. His willingness to help, share insight, and support others speaks volumes about his character and leadership.
Michael Harman is a strong positive influence in the ME Tech world. He offered a lot of valuable insight to our class and especially to me at the beginning of my entrepreneur journey. Directing me to pursue a ‘Design for Manufacturing”. I am very grateful. Thank you.
Mike is an exceptional connector with a rare ability to bring the right people together to solve complex problems. His insight, proactive support, and genuine commitment to helping others succeed have had a meaningful impact on my career and many others.
Mike is deeply driven by helping others succeed and advancing meaningful medical innovation. His passion, selflessness, and ability to elevate the work of those around him make him an exceptional force in the medical technology community.
Michael quickly understands where you are and adapts his guidance with clarity and ease. His expertise and steady approach made our work efficient, valuable, and confidence-building.
Michael brought strong energy, commitment, and insight to our project. His openness to feedback and clear communication made him a valuable partner I’d gladly work with again.
Michael has helped me multiple times with industry contacts in a timely fashion. Most recently, he connected me to a valuable strategic connection for my company fundraising efforts!
Michael brings deep expertise across product development and commercialization. His leadership, clear communication, and ability to motivate teams consistently drive strong outcomes.
Michael was a trusted advisor who consistently brought clarity to complex technologies. His clear communication and reliable guidance played a key role in winning competitive development programs.
Founders, executives, and investors share their experiences working with strategic medical leadership focused on execution, clarity, and results.
Get clear, senior-level guidance to move medical technologies forward with confidence and focus.
Strategic partnership for teams ready to move from vision to execution.
Insights on commercialization strategy, drug development, and bridging the gap between research and real-world impact.
